Shareholders approve CME's Nymex takeover

The cash and share deal, announced in March, values Nymex at $8.3 billion, and will see Nymex members bought out for $750,000 each.

Nymex members finally approved the takeover after six months of wooing from CME, culminating in the decision last month to raise the buyout payment from $612,000. The deal should close at the end of this week, opening the way for a predicted $60 million in cost cuts - which could include job losses at the New York exchange.

See also: CME Group buys Nymex and offloads metals
CME faces competition questions from DOJ 
CME in Nymex merger discussions
Donohue: further exchange consolidation ahead 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here